Clinical Trial Update: A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update documenting pharmacokinetics, safety, and tolerability assessment of Abexinostat in Chinese patients with Non-Hodgkin lymphoma (Phase 1/Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Abexinostat (Abexinostat)

Snippet

Sponsor: Xynomic Pharmaceuticals, Inc. | Conditions: Non Hodgkin Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING